CD133+CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patients

作者
Shanshan Zhang,Zhipeng Han,Ying-ying Jing,Shuangfen Tao,Tiejun Li,Hao Wang,Yang Wang,Rong Li,Yang� Yang,Xue Zhao,Xiaodong Xu,Enda Yu,Yao‐Cheng Rui,Liu Hou-jia,Li Zhang,Lixin Wei
出处
期刊:BMC Medicine [BioMed Central]
卷期号:10 (1): 85-85 被引量:164
标识
DOI:10.1186/1741-7015-10-85
摘要

BACKGROUND: Colorectal cancer (CRC), which frequently metastasizes to the liver, is one of the three leading causes of cancer-related deaths worldwide. Growing evidence suggests that a subset of cells exists among cancer stem cells. This distinct subpopulation is thought to contribute to liver metastasis; however, it has not been fully explored in CRC yet. METHODS: Flow cytometry analysis was performed to detect distinct subsets with CD133 and CXCR4 markers in human primary and metastatic CRC tissues. The 'stemness' and metastatic capacities of different subpopulations derived from the colon cancer cell line HCT116 were compared in vitro and in vivo. The roles of epithelial-mesenchymal transition (EMT) and stromal-cell derived factor-1 (SDF-1) in the metastatic process were also investigated. A survival curve was used to explore the correlation between the content of CD133(+)CXCR4(+) cancer cells and patient survival. RESULTS: In human specimens, the content of CD133(+)CXCR4(+) cells was higher in liver metastases than in primary colorectal tumors. Clonogenic and tumorigenic cells were restricted to CD133(+) cells in the HCT116 cell line, with CXCR4 expression having no impact on the 'stemness' properties. We found that CD133(+)CXCR4(+)cancer cells had a high metastatic capacity in vitro and in vivo. Compared with CD133(+)CXCR4(-) cells, CD133(+)CXCR4(+)cancer cells experienced EMT, which contributed partly to their metastatic phenotype. We then determined that SDF-1/CXCL12 treatment could further induce EMT in CD133(+)CXCR4(+)cancer cells and enhance their invasive behavior, while this could not be observed in CD133(+)CXCR4- cancer cells. Blocking SDF-1/CXCR4 interaction with a CXCR4 antagonist, AMD3100 (1,10-[1,4-phenylenebis(methylene)]bis-1,4,8,11 -tetraazacyclotetradecane octahydrochloride), inhibited metastatic tumor growth in a mouse hepatic metastasis model. Finally, a high percentage of CD133(+)CXCR4(+)cells in human primary CRC was associated with a reduced two-year survival rate. CONCLUSIONS: Strategies targeting the SDF-1/CXCR4 interaction may have important clinical applications in the suppression of colon cancer metastasis. Further investigations on how high expression of CXCR4 and EMT occur in this identified cancer stem cell subset are warranted to provide insights into our understanding of tumor biology.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小二郎的应助被niiiiii采纳,获得10
刚刚
刚刚
赘婿的应助被科研通管家采纳,获得20
刚刚
宋宋完成签到,获得积分10
1秒前
七七完成签到,获得积分10
1秒前
丘比特的应助被科研通管家采纳,获得10
1秒前
一切顺利tsy完成签到,获得积分10
1秒前
深情安青的应助被科研通管家采纳,获得10
1秒前
Ren完成签到,获得积分0
1秒前
Owen的应助被科研通管家采纳,获得20
1秒前
彭于彦祖的应助被博修采纳,获得30
1秒前
bkagyin的应助被科研通管家采纳,获得10
1秒前
wanci的应助被科研通管家采纳,获得10
1秒前
1秒前
亳亳发布了新的文献求助10
1秒前
思源的应助被科研通管家采纳,获得10
1秒前
1秒前
脑洞疼的应助被科研通管家采纳,获得10
2秒前
忐忑的琦完成签到,获得积分10
2秒前
科目三的应助被科研通管家采纳,获得10
2秒前
英姑的应助被科研通管家采纳,获得10
2秒前
里哈哈发布了新的文献求助10
2秒前
上官若男的应助被科研通管家采纳,获得10
2秒前
大模型的应助被科研通管家采纳,获得10
2秒前
Pan完成签到,获得积分10
2秒前
激动的雅琴完成签到 ,获得积分10
2秒前
汉堡包的应助被科研通管家采纳,获得10
2秒前
2秒前
共享精神的应助被科研通管家采纳,获得10
2秒前
3秒前
情怀的应助被科研通管家采纳,获得10
3秒前
哈哈发布了新的文献求助10
3秒前
3秒前
3秒前
我是老大的应助被科研通管家采纳,获得10
3秒前
shen的应助被科研通管家采纳,获得50
3秒前
3秒前
香蕉觅云的应助被科研通管家采纳,获得10
3秒前
3秒前
3秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185